Palvella Therapeutics (PVLA) Institutional Ownership $24.36 -0.04 (-0.16%) As of 04/17/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Palvella Therapeutics (NASDAQ:PVLA)CurrentInstitutional OwnershipPercentage40.11%Number ofInstitutional Buyers(last 12 months)15TotalInstitutional Inflows(last 12 months)$48.07MNumber ofInstitutional Sellers(last 12 months)0 Get PVLA Insider Trade Alerts Want to know when executives and insiders are buying or selling Palvella Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PVLA Institutional Buying and Selling by Quarter Palvella Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/19/2025Toronto Dominion Bank13,211$159K0.0%N/A0.118% 2/18/2025Frazier Life Sciences Management L.P.653,892$7.85M0.3%N/A5.828% 2/17/2025Toronto Dominion Bank13,211$159K0.0%N/A0.118% 2/17/2025Suvretta Capital Management LLC714,463$8.57M0.3%N/A6.367% 2/17/2025DAFNA Capital Management LLC71,452$857K0.2%N/A0.637% 2/17/2025Cresset Asset Management LLC20,911$251K0.0%N/A0.186% 2/17/2025Citadel Advisors LLC10,408$125K0.0%N/A0.093% 2/17/2025BVF Inc. IL696,555$8.36M0.3%N/A6.208% 2/17/2025Adams Street Partners LLC409,666$4.92M4.4%N/A3.651% 2/14/2025Samsara BioCapital LLC679,486$8.15M1.1%N/A6.056% 2/14/2025Nantahala Capital Management LLC250,062$3.00M0.1%N/A2.229% 2/14/2025Blue Owl Capital Holdings LP250,062$3.00M0.7%N/A2.229% 2/13/2025Renaissance Technologies LLC21,371$256K0.0%N/A0.190% 2/13/2025ADAR1 Capital Management LLC144,641$1.74M0.3%N/A1.289% 2/12/2025Geode Capital Management LLC14,270$171K0.0%N/A0.127% 2/7/2025BML Capital Management LLC42,130$506K0.3%N/A0.375% (Data available from 1/1/2016 forward) PVLA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PVLA shares? During the previous two years, 15 institutional investors and hedge funds held shares of Palvella Therapeutics. The most heavily invested institutionals were Suvretta Capital Management LLC ($8.57M), BVF Inc. IL ($8.36M), Samsara BioCapital LLC ($8.15M), Frazier Life Sciences Management L.P. ($7.85M), Adams Street Partners LLC ($4.92M), Blue Owl Capital Holdings LP ($3.00M), and Nantahala Capital Management LLC ($3.00M).Learn more on PVLA's institutional investors. What percentage of Palvella Therapeutics stock is owned by institutional investors? 40.11% of Palvella Therapeutics stock is owned by institutional investors. Learn more on PVLA's institutional investor holdings. Which institutional investors have been buying Palvella Therapeutics stock? Of the 15 institutional investors that purchased Palvella Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Suvretta Capital Management LLC ($714.46K), BVF Inc. IL ($696.56K), Samsara BioCapital LLC ($679.49K), Frazier Life Sciences Management L.P. ($653.89K), Adams Street Partners LLC ($409.67K), Blue Owl Capital Holdings LP ($250.06K), and Nantahala Capital Management LLC ($250.06K). How much institutional buying is happening at Palvella Therapeutics? Institutional investors have bought a total of 4,005,791 shares in the last 24 months. This purchase volume represents approximately $48.07M in transactions. Related Companies GPCR Institutional Ownership AUPH Institutional Ownership IOVA Institutional Ownership SNDX Institutional Ownership WVE Institutional Ownership DYN Institutional Ownership COLL Institutional Ownership ETNB Institutional Ownership MLYS Institutional Ownership RCUS Institutional Ownership This page (NASDAQ:PVLA) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Palvella Therapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Share Palvella Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
